Exelixis, Inc. today announced that the company's Board of Directors has authorized the repurchase of up to an additional $500 million of the company's common stock before December 31, 2025. Exelixis ...

As tech companies launch agentic AI that can execute tasks as well as generate content and reason, banks are putting frameworks and controls in place to start taking advantage.

Full year operating cash flow, when adjusted for onetime transaction and separation costs, was $342 million. This represents an operating cash flow conversion rate of 58% consistent with our annual ...

Telix has also provided R&D expenditure guidance, expecting an increased investment range of 20% to 25% compared to FY2024. An investor webcast will be held at 9.00am AEDT on Friday 21 February 2025 ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in TD Cowen's 45th Annual Health Care Conference. Company management ...

Q4 2024 - Earnings Conference Call February 20, 2025 8:00 AM ETCompany ParticipantsTravis Hess - CEODaniel Lentz ...

Closed investments of $330.8 million at a weighted average initial cash yield 9.3% in 2024 –– Raised $165.2 million of net proceeds under ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in TD Cowen's 45th Annual Health Care Conference. Company management will participate in a fireside chat on ...

Operator Good morning, and welcome to the Hasbro fourth quarter and full year 2024 earnings conference call. [Operator ...

Pulse Biosciences, Inc. , a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablationtm (nano-PFA or nsPFAtm) technology, today announced plans to present at the upcoming TD Cowen ...

Operator Good day, everyone, and welcome to the Exact Sciences fourth quarter 2024 earnings call. Today's call is being ...

Our continued international expansion and consolidation in top markets, combined with our Company's rebranding, heralds a new ...